We found that chronic amiodarone administration has no significant effect—either positive or negative—on the evolution of LV remodeling post-MI at the tissue (myocyte size, vascular density and interstitial fibrosis), organ (LV structure and function) and systemic level (levels of circulating BNP and MMP-9). The gene discussed is NPPB; the disease is myocardial infarction.